Chief Executive Officer
Founded in 1953, the Canadian Hemophilia Society (CHS) is a national non-profit organization. Its mission is to advocate to improve the health and quality of life for all people in Canada living with an inherited bleeding disorder until cures are universally available. Its vision is a world free from the pain and suffering of inherited bleeding disorders. With national headquarters in Montreal and approximately 300 active volunteers across the country, the CHS works at the national, provincial, and local levels. The ten provincial chapters across Canada are each managed by its own Board. The organization’s national Board of Directors is skills/competencies based and comprised of individuals from across Canada who bring valued expertise. The CHS works in collaboration with health care providers in Canada’s 26 inherited bleeding disorder treatment centres, the blood system operators (Canadian Blood Services and Héma-Québec), the Network of Rare Blood Disorder Organizations, the hepatitis C community, the AIDS community, and others who share the CHS’ common interests.
The CHS is seeking a new and outstanding Chief Executive Officer (CEO) to lead the organization through its next stage of transformation, growth, and modernization. Reporting to the national Board of Directors and working with a team of seven staff members, the CEO has responsibility for all facets of the CHS’ operations and activities and provides effective leadership to ensure that the CHS operates to fulfil its mission and mandate. As the CHS is at a critical point in its history, a renewed focus on the organization’s national fundraising program and identifying and developing additional revenue streams will be a critical responsibility for the new CEO.
What it takes:
- A strategic thinker and self-starter, with a proven track record as a manager and administrator of an organization of similar size and scope
- Experience in a leadership role requiring vision and direction, building enthusiasm to achieve strategic and operational goals
- Efficient in overall program direction, annual action plan, budget and financial reporting are key elements of the position
- Experience working with, recruiting and motivating a volunteer base
- Exposure to fundraising and a deep understanding of the competitive philanthropic landscape in Canada
- Creativity for how to open doors, generate business alliances and partnership opportunities to position the CHS for long-term sustainability
- Ability to support a national Board of Directors
- Strong external relations (including with pharmaceutical companies)
- Bilingualism is a significant asset, as is proximity to the Montreal office
Position impact:
This is a compelling opportunity for an individual who thrives on transformation with the vision to see it through and a strong desire to make a lasting impact on those affected by inherited bleeding disorders.
Applications are encouraged immediately and should be submitted online ideally by March 18, 2022 at www.odgersberndtson.com/en/careers/17883. For more information, please contact Kyle Mechar of Odgers Berndtson at kyle.mechar@odgersberndtson.com. We thank all those who express an interest, however only those chosen for further development will be contacted.
The Canadian Hemophilia Society is an equal opportunity employer. In accordance with the Accessible Canada Act, 2019 and all applicable provincial accessibility standards, upon request, accommodation will be provided by both Odgers Berndtson and Canadian Hemophilia Society throughout the recruitment, selection and/or assessment process to applicants with disabilities.
Odgers Berndtson is deeply committed to diversity, equity and inclusion in all the work that we do. As part of our efforts to better understand our ability to reach as broad a pool of candidates as possible for our searches, our DEI team would like to encourage you to take a moment and access our Self-Declaration Form.